KRAIG BIOCRAFT LABORATORIES, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $55.19 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-13
- KRAIG BIOCRAFT LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- KRAIG BIOCRAFT LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $0.00.
- KRAIG BIOCRAFT LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00.
- KRAIG BIOCRAFT LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-06-30 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $55.19K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-13 | $140.04K 10-Q · filed 2026-08-13 | ||
| 2025-09-30 | $140.04K 10-Q · filed 2025-11-12 | |||
| 2024-12-31 | $0.00 derived: POS AM 12 month − 10-Q 9 month · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $30.08K POS AM · filed 2026-05-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $30.08K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $30.08K 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | $30.08K 10-Q · filed 2024-05-14 | |||
| 2019-09-30 | $27.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $47.39K derived: sum of 2 quarters · filed 2019-11-13 | $58.12K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $19.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $30.43K 10-Q · filed 2019-08-12 | ||
| 2019-03-31 | $10.74K 10-Q · filed 2019-05-13 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 |